<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37386082</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>A human proteogenomic-cellular framework identifies KIF5A as a modulator of astrocyte process integrity with relevance to ALS.</ArticleTitle><Pagination><StartPage>678</StartPage><MedlinePgn>678</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">678</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-023-05041-4</ELocationID><Abstract><AbstractText>Genome-wide association studies identified several disease-causing mutations in neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). However, the contribution of genetic variants to pathway&#xa0;disturbances and their cell type-specific variations, especially in glia, is poorly understood. We integrated ALS GWAS-linked gene networks with human astrocyte-specific multi-omics datasets to elucidate pathognomonic signatures. It predicts that KIF5A, a motor protein kinesin-1 heavy-chain isoform, previously detected only in neurons, can also potentiate disease pathways in astrocytes. Using postmortem tissue and super-resolution structured illumination microscopy in cell-based perturbation platforms, we provide evidence that KIF5A is present in astrocyte processes and its deficiency disrupts structural integrity and mitochondrial transport. We show that this may underly cytoskeletal and trafficking changes in SOD1 ALS astrocytes characterised by low KIF5A levels, which can be rescued by c-Jun N-terminal Kinase-1 (JNK1), a kinesin transport regulator. Altogether, our pipeline reveals a mechanism controlling astrocyte process integrity, a pre-requisite for synapse maintenance and suggests a targetable loss-of-function in ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Szeb&#xe9;nyi</LastName><ForeName>Korn&#xe9;lia</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1558-8372</Identifier><AffiliationInfo><Affiliation>John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0PY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Enzymology, Research Centre for Natural Sciences, Budapest, 1117, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Barrio-Hernandez</LastName><ForeName>Inigo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, CB10 1SD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibbons</LastName><ForeName>George M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0PY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biasetti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troakes</LastName><ForeName>Claire</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1790-7376</Identifier><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltrao</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2724-7703</Identifier><AffiliationInfo><Affiliation>European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, CB10 1SD, UK. pedrobeltrao@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular Systems Biology, ETH Z&#xfc;rich, Z&#xfc;rich, 8093, Switzerland. pedrobeltrao@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakatos</LastName><ForeName>Andr&#xe1;s</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1301-2292</Identifier><AffiliationInfo><Affiliation>John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0PY, UK. AL291@cam.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK. AL291@cam.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.4.4</RegistryNumber><NameOfSubstance UI="D016547">Kinesins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C500506">KIF5A protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016547" MajorTopicYN="N">Kinesins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071696" MajorTopicYN="Y">Proteogenomics</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare the following competing interests: A.L. is a scientific consultant to Tachyon Ventures, a venture capital firm (Los Angeles, California, USA). All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37386082</ArticleId><ArticleId IdType="pmc">PMC10310856</ArticleId><ArticleId IdType="doi">10.1038/s42003-023-05041-4</ArticleId><ArticleId IdType="pii">10.1038/s42003-023-05041-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Du Y, et al. A genome-wide expression association analysis identifies genes and pathways associated with amyotrophic lateral sclerosis. Cell. Mol. Neurobiol. 2018;38:635&#x2013;639. doi: 10.1007/s10571-017-0512-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-017-0512-2</ArticleId><ArticleId IdType="pubmed">28639078</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 2016;48:481&#x2013;487. doi: 10.1038/ng.3538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3538</ArticleId><ArticleId IdType="pubmed">27019110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YA, Kammenga JE, Harvey SC. Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans. Hum. Genomics. 2017;11:1&#x2013;10. doi: 10.1186/s40246-017-0108-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-017-0108-4</ArticleId><ArticleId IdType="pmc">PMC5445269</ArticleId><ArticleId IdType="pubmed">28545550</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu V, et al. Natural variation in gene expression modulates the severity of mutant phenotypes. Cell. 2015;162:391&#x2013;402. doi: 10.1016/j.cell.2015.06.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.06.037</ArticleId><ArticleId IdType="pubmed">26186192</ArticleId></ArticleIdList></Reference><Reference><Citation>Saez-Atienzar S, et al. Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types. Sci. Adv. 2021;7:1&#x2013;14. doi: 10.1126/sciadv.abd9036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd9036</ArticleId><ArticleId IdType="pmc">PMC7810371</ArticleId><ArticleId IdType="pubmed">33523907</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I, Blom UM, Wang PI, Shim JE, Marcotte EM. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res. 2011;21:1109&#x2013;1121. doi: 10.1101/gr.118992.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.118992.110</ArticleId><ArticleId IdType="pmc">PMC3129253</ArticleId><ArticleId IdType="pubmed">21536720</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke L, et al. Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. Am. J. Hum. Genet. 2006;78:1011&#x2013;1025. doi: 10.1086/504300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/504300</ArticleId><ArticleId IdType="pmc">PMC1474084</ArticleId><ArticleId IdType="pubmed">16685651</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang H, et al. A genetics-led approach defines the drug target landscape of 30 immune-related traits. Nat. Genet. 2019;51:1082&#x2013;1091. doi: 10.1038/s41588-019-0456-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0456-1</ArticleId><ArticleId IdType="pmc">PMC7124888</ArticleId><ArticleId IdType="pubmed">31253980</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanunu, O., Magger, O., Ruppin, E., Shlomi, T. &amp; Sharan, R. Associating genes and protein complexes with disease via network propagation. PLoS Comput. Biol. 6, e1000641 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2797085</ArticleId><ArticleId IdType="pubmed">20090828</ArticleId></ArticleIdList></Reference><Reference><Citation>MacNamara A, et al. Network and pathway expansion of genetic disease associations identifies successful drug targets. Sci. Rep. 2020;10:1&#x2013;11. doi: 10.1038/s41598-020-77847-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77847-9</ArticleId><ArticleId IdType="pmc">PMC7708424</ArticleId><ArticleId IdType="pubmed">33262371</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Harten ACM, Phatnani H, Przedborski S. Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis. Trends Neurosci. 2021;44:658&#x2013;668. doi: 10.1016/j.tins.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8972039</ArticleId><ArticleId IdType="pubmed">34006386</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 2021;24:312&#x2013;325. doi: 10.1038/s41593-020-00783-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00783-4</ArticleId><ArticleId IdType="pmc">PMC8007081</ArticleId><ArticleId IdType="pubmed">33589835</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack GE, et al. A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models. Nat. Commun. 2017;8:1164. doi: 10.1038/s41467-017-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01283-z</ArticleId><ArticleId IdType="pmc">PMC5660125</ArticleId><ArticleId IdType="pubmed">29079839</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, et al. Hot-spot KIF5A mutations cause familial ALS. Brain. 2018;141:688&#x2013;697. doi: 10.1093/brain/awx370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx370</ArticleId><ArticleId IdType="pmc">PMC5837483</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;1283.e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW. Neuronal growth and death: Order and disorder in the axoplasm. Cell. 1996;84:663&#x2013;666. doi: 10.1016/S0092-8674(00)81044-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81044-2</ArticleId><ArticleId IdType="pubmed">8625404</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia CH, et al. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J. Cell Biol. 2003;161:55&#x2013;66. doi: 10.1083/jcb.200301026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200301026</ArticleId><ArticleId IdType="pmc">PMC2172877</ArticleId><ArticleId IdType="pubmed">12682084</ArticleId></ArticleIdList></Reference><Reference><Citation>Pletscher-Frankild S, Pallej&#xe0; A, Tsafou K, Binder JX, Jensen LJ. DISEASES: Text mining and data integration of disease-gene associations. Methods. 2015;74:83&#x2013;89. doi: 10.1016/j.ymeth.2014.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2014.11.020</ArticleId><ArticleId IdType="pubmed">25484339</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan L, Cookson MR, Petrucelli L, La Spada AR. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat. Neurosci. 2018;21:1300&#x2013;1309. doi: 10.1038/s41593-018-0237-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0237-7</ArticleId><ArticleId IdType="pmc">PMC6278826</ArticleId><ArticleId IdType="pubmed">30258237</ArticleId></ArticleIdList></Reference><Reference><Citation>Moller A, Bauer CS, Cohen RN, Webster CP, De Vos KJ. Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels. Hum. Mol. Genet. 2017;26:4668&#x2013;4679. doi: 10.1093/hmg/ddx348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx348</ArticleId><ArticleId IdType="pmc">PMC5886184</ArticleId><ArticleId IdType="pubmed">28973175</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli L, et al. C9orf72-derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility. Sci. Adv. 2021;7:19&#x2013;23. doi: 10.1126/sciadv.abg3013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg3013</ArticleId><ArticleId IdType="pmc">PMC8034861</ArticleId><ArticleId IdType="pubmed">33837088</ArticleId></ArticleIdList></Reference><Reference><Citation>Daire V, et al. Kinesin-1 regulates microtubule dynamics via a c-Jun N-terminal kinase-dependent mechanism. J. Biol. Chem. 2009;284:31992&#x2013;32001. doi: 10.1074/jbc.M109.007906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.007906</ArticleId><ArticleId IdType="pmc">PMC2797271</ArticleId><ArticleId IdType="pubmed">19759393</ArticleId></ArticleIdList></Reference><Reference><Citation>Khakh BS, Sofroniew MV. Diversity of astrocyte functions and phenotypes in neural circuits. Nat. Neurosci. 2015;18:942&#x2013;952. doi: 10.1038/nn.4043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4043</ArticleId><ArticleId IdType="pmc">PMC5258184</ArticleId><ArticleId IdType="pubmed">26108722</ArticleId></ArticleIdList></Reference><Reference><Citation>Peet DR, Burroughs NJ, Cross RA. Kinesin expands and stabilizes the GDP-microtubule lattice. Nat. Nanotechnol. 2018;13:386&#x2013;391. doi: 10.1038/s41565-018-0084-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41565-018-0084-4</ArticleId><ArticleId IdType="pmc">PMC5937683</ArticleId><ArticleId IdType="pubmed">29531331</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell PD, et al. Unique function of kinesin Kif5A in localization of mitochondria in axons. J. Neurosci. 2014;34:14717&#x2013;14732. doi: 10.1523/JNEUROSCI.2770-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2770-14.2014</ArticleId><ArticleId IdType="pmc">PMC4212069</ArticleId><ArticleId IdType="pubmed">25355224</ArticleId></ArticleIdList></Reference><Reference><Citation>Attwood MM, Fabbro D, Sokolov AV, Knapp S, Schi&#xf6;th HB. Trends in kinase drug discovery: targets, indications and inhibitor design. Nat. Rev. Drug Discov. 2021;20:839&#x2013;861. doi: 10.1038/s41573-021-00252-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-021-00252-y</ArticleId><ArticleId IdType="pubmed">34354255</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessa C, et al. Discovery of a small-molecule protein kinase C&#x3b4;-selective activator with promising application in colon cancer therapy article. Cell Death Dis. 2018;9:23. doi: 10.1038/s41419-017-0154-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0154-9</ArticleId><ArticleId IdType="pmc">PMC5833815</ArticleId><ArticleId IdType="pubmed">29348560</ArticleId></ArticleIdList></Reference><Reference><Citation>Genda EN, et al. Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria. J. Neurosci. 2011;31:18275&#x2013;18288. doi: 10.1523/JNEUROSCI.3305-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3305-11.2011</ArticleId><ArticleId IdType="pmc">PMC3259858</ArticleId><ArticleId IdType="pubmed">22171032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I, et al. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Sci. (80-.). 2014;345:1139&#x2013;1145. doi: 10.1126/science.1254917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254917</ArticleId><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland DS, et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) Proc. Natl Acad. Sci. Usa. 2002;99:1604&#x2013;1609. doi: 10.1073/pnas.032539299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.032539299</ArticleId><ArticleId IdType="pmc">PMC122237</ArticleId><ArticleId IdType="pubmed">11818550</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W, et al. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur. J. Hum. Genet. 2018;26:1537&#x2013;1546. doi: 10.1038/s41431-018-0177-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0177-4</ArticleId><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer EMJ, et al. Genotype-phenotype correlations of KIF5A stalk domain variants. Amyotroph. Lateral Scler. Front. Degener. 2021;0:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">33829936</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid E, et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10) Am. J. Hum. Genet. 2002;71:1189&#x2013;1194. doi: 10.1086/344210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/344210</ArticleId><ArticleId IdType="pmc">PMC385095</ArticleId><ArticleId IdType="pubmed">12355402</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano J, Chiba K, Niwa S. An ALS-associated KIF5A mutant forms oligomers and aggregates and induces neuronal toxicity. Genes Cells. 2022;27:421&#x2013;435. doi: 10.1111/gtc.12936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12936</ArticleId><ArticleId IdType="pmc">PMC9322661</ArticleId><ArticleId IdType="pubmed">35430760</ArticleId></ArticleIdList></Reference><Reference><Citation>Pant DC, et al. ALS &#x2010;linked KIF5A &#x394;Exon27 mutant causes neuronal toxicity through gain&#x2010;of&#x2010;function. EMBO Rep. 2022;23:1&#x2013;18. doi: 10.15252/embr.202154234.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202154234</ArticleId><ArticleId IdType="pmc">PMC9346498</ArticleId><ArticleId IdType="pubmed">35735139</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron DM, et al. ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function. Cell Rep. 2022;39:110598. doi: 10.1016/j.celrep.2022.110598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.110598</ArticleId><ArticleId IdType="pmc">PMC9134378</ArticleId><ArticleId IdType="pubmed">35385738</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, et al. Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes. J. Neurol. Neurosurg. Psychiatry. 2019;90:861&#x2013;869. doi: 10.1136/jnnp-2018-319386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319386</ArticleId><ArticleId IdType="pmc">PMC6691870</ArticleId><ArticleId IdType="pubmed">30992335</ArticleId></ArticleIdList></Reference><Reference><Citation>Haydon PG, Nedergaard M. How do astrocytes participate in neural plasticity? Cold Spring Harb. Perspect. Biol. 2015;7:1&#x2013;16. doi: 10.1101/cshperspect.a020438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020438</ArticleId><ArticleId IdType="pmc">PMC4355266</ArticleId><ArticleId IdType="pubmed">25502516</ArticleId></ArticleIdList></Reference><Reference><Citation>Landers JE, et al. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. Usa. 2009;106:9004&#x2013;9009. doi: 10.1073/pnas.0812937106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812937106</ArticleId><ArticleId IdType="pmc">PMC2683883</ArticleId><ArticleId IdType="pubmed">19451621</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsetti, V. et al. Genetic variation in KIFAP3 is associated with an upper motor neuron-predominant phenotype in amyotrophic lateral sclerosis. Neurodegener Dis.8, 491&#x2013;495 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21659726</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, et al. Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients. Proc. Natl Acad. Sci. Usa. 2010;107:12335&#x2013;12338. doi: 10.1073/pnas.0914079107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0914079107</ArticleId><ArticleId IdType="pmc">PMC2901467</ArticleId><ArticleId IdType="pubmed">20566859</ArticleId></ArticleIdList></Reference><Reference><Citation>Czell D, et al. Further analysis of KIFAP3 gene in ALS patients from Switzerland and Sweden. Amyotroph. Lateral Scler. Front. Degener. 2017;18:302&#x2013;304. doi: 10.1080/21678421.2017.1280509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1280509</ArticleId><ArticleId IdType="pubmed">28140676</ArticleId></ArticleIdList></Reference><Reference><Citation>Oelz DB, del Castillo U, Gelfand VI, Mogilner A. Microtubule dynamics, kinesin-1 sliding, and dynein action drive growth of cell processes. Biophys. J. 2018;115:1614&#x2013;1624. doi: 10.1016/j.bpj.2018.08.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2018.08.046</ArticleId><ArticleId IdType="pmc">PMC6260207</ArticleId><ArticleId IdType="pubmed">30268540</ArticleId></ArticleIdList></Reference><Reference><Citation>Randall TS, et al. A small-molecule activator of kinesin-1 drives remodeling of the microtubule network. Proc. Natl Acad. Sci. Usa. 2017;114:13738&#x2013;13743. doi: 10.1073/pnas.1715115115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1715115115</ArticleId><ArticleId IdType="pmc">PMC5748212</ArticleId><ArticleId IdType="pubmed">29229862</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini GA, et al. Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PLoS One. 2013;8:e65235. doi: 10.1371/journal.pone.0065235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0065235</ArticleId><ArticleId IdType="pmc">PMC3680447</ArticleId><ArticleId IdType="pubmed">23776455</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf3;rotz GM, et al. Amyotrophic lateral sclerosis-associated mutant VAPBP56s perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum. Mol. Genet. 2012;21:1979&#x2013;1988. doi: 10.1093/hmg/dds011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds011</ArticleId><ArticleId IdType="pmc">PMC3315205</ArticleId><ArticleId IdType="pubmed">22258555</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda K, Clatterbuck-Soper SF, Jackrel ME, Shorter J, Mili S. FUS inclusions disrupt RNA localization by sequestering kinesin-1 and inhibiting microtubule detyrosination. J. Cell Biol. 2017;216:1015&#x2013;1034. doi: 10.1083/jcb.201608022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201608022</ArticleId><ArticleId IdType="pmc">PMC5379945</ArticleId><ArticleId IdType="pubmed">28298410</ArticleId></ArticleIdList></Reference><Reference><Citation>Padzik A, et al. KIF5C S176 phosphorylation regulates microtubule binding and transport efficiency in mammalian neurons. Front. Cell. Neurosci. 2016;10:1&#x2013;15. doi: 10.3389/fncel.2016.00057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00057</ArticleId><ArticleId IdType="pmc">PMC4791394</ArticleId><ArticleId IdType="pubmed">27013971</ArticleId></ArticleIdList></Reference><Reference><Citation>Haydon PG. GLIA: listening and talking to the synapse. Nat. Rev. Neurosci. 2001;2:185&#x2013;193. doi: 10.1038/35058528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35058528</ArticleId><ArticleId IdType="pubmed">11256079</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 1995;38:73&#x2013;84. doi: 10.1002/ana.410380114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380114</ArticleId><ArticleId IdType="pubmed">7611729</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V, et al. Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow. Nat. Commun. 2020;11:5579. doi: 10.1038/s41467-020-19177-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19177-y</ArticleId><ArticleId IdType="pmc">PMC7642391</ArticleId><ArticleId IdType="pubmed">33149111</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CE, et al. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS. Cell Rep. 2017;19:1739&#x2013;1749. doi: 10.1016/j.celrep.2017.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.024</ArticleId><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicinanza, M., Gratian, M. J., Bowen, M. &amp; Rubinsztein, D. C. Fluorescence-based assays to analyse phosphatidylinositol 5-phosphate in autophagy. Methods Enzymol.587, 311&#x2013;330 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28253963</ArticleId></ArticleIdList></Reference><Reference><Citation>Szeb&#xe9;nyi K, et al. Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology. Nat. Neurosci. 2021;24:1542&#x2013;1554. doi: 10.1038/s41593-021-00923-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00923-4</ArticleId><ArticleId IdType="pmc">PMC8553627</ArticleId><ArticleId IdType="pubmed">34675437</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>